Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy-Reference-Cited by-同舟云学术

Palonosetron is nonsuperior to ondansetron in acute phase but provides superior antiemetic control in delayed phase for pediatric patients administered highly emetogenic chemotherapy

Published:2017-09-22 Issue:2 Volume:65 Page:e26815
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Tan Juan¹,Wang Shan²³,Liang Xiaohua³,Li Chang-Chun²³,Zhang Jun²³,Zhao Zhenzhen²³,Kong Xiang-Ru²³,Deng Xiaobin²³,Peng Liang²³,Yang Chao²³^ORCID

Affiliation:

1. Outpatient Department of Children's Hospital of Chongqing Medical University; Lijia Campus; Chongqing China

2. Department of Pediatric Surgical Oncology; Children's Hospital of Chongqing Medical University; Chongqing China

3. Ministry of Education Key Laboratory of Child Development and Disorders; The Children's Hospital of Chongqing Medical University; Chongqing China

Funder

National Clinical Key Subject Construction Project

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference20 articles.

1. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics;Grunberg;Cancer,2004

2. Antiemetics: American Society of Clinical Oncology clinical practice guideline update;Basch;J Clin Oncol,2011

3. National Comprehensive Cancer Network (NCCN) NCCN Clinical Practice Guidelines in Oncology version 2 2016

4. 2016 Updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high emetic risk chemotherapy;Herrstedt;Support Care Cancer,2017

5. Antiemetics in children receiving chemotherapy. MASCC/ESMO guideline update 2009;Jordan;Support Care Cancer,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palonosetron in pediatric patients: A single-center, retrospective evaluation of policy and clinical practice guideline discordance;Journal of Oncology Pharmacy Practice;2024-02-29

2. Palonosetron for prevention of delayed chemotherapy-induced nausea and vomiting in pediatric patients: a meta-analysis;Supportive Care in Cancer;2023-12-26

3. Clinician preference and comparison of the efficacy of ondansetron, granisetron, and palonosetron in preventing chemotherapy-induced nausea and vomiting among children receiving moderate or highly emetogenic chemotherapy;Pediatric Hematology Oncology Journal;2023-09

4. Optimizing antiemetic therapy for children undergoing chemotherapy;Journal of Pediatric Nursing;2022-09

5. Does a single dose of palonosetron have any role in preventing acute chemotherapy-induced nausea and vomiting in pediatric osteosarcoma patients without dexamethasone? A randomized clinical trial;Advances in Clinical and Experimental Medicine;2022-03-16